RESEARCHER PROFILE

Yi Li

← Back to Chongqing University

Y

Chongqing University

Cancer Cells and MetastasisBreast Cancer Treatment StudiesWnt/β-catenin signaling in development and cancerCell death mechanisms and regulationCancer-related Molecular Pathways

Yi Li works in Cancer Cells and Metastasis, Breast Cancer Treatment Studies, Wnt/β-catenin signaling in development and cancer, Cell death mechanisms and regulation, Cancer-related Molecular Pathways. Recorded institutional associations include Chongqing University, Baylor College of Medicine, Jilin University.

1,031Publications
27,989Citations
78H-index

Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.

Selected research works

Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.

  1. AAV Vector Integration Sites in Mouse Hepatocellular Carcinoma

    2007 · 662 citations
  2. Evidence that transgenes encoding components of the Wnt signaling pathway preferentially induce mammary cancers from progenitor cells

    2003 · 521 citations
  3. A genome-wide association study of nasopharyngeal carcinoma identifies three new susceptibility loci

    2010 · 410 citations
  4. Endothelial infection with KSHV genes in vivo reveals that vGPCR initiates Kaposi's sarcomagenesis and can promote the tumorigenic potential of viral latent genes

    2003 · 373 citations
  5. Non-viral, specifically targeted CAR-T cells achieve high safety and efficacy in B-NHL

    2022 · 371 citations
  6. Induction of ovarian cancer by defined multiple genetic changes in a mouse model system

    2002 · 358 citations
  7. Disease-related expression of the IL6/STAT3/SOCS3 signalling pathway in ulcerative colitis and ulcerative colitis-related carcinogenesis

    2009 · 337 citations
  8. p53-Mediated Senescence Impairs the Apoptotic Response to Chemotherapy and Clinical Outcome in Breast Cancer

    2012 · 328 citations
  9. Immuno-subtyping of breast cancer reveals distinct myeloid cell profiles and immunotherapy resistance mechanisms

    2019 · 327 citations
  10. Monoclonal TCR-redirected tumor cell killing

    2012 · 324 citations
  11. A Genome-Wide Association Study Identifies Novel and Functionally Related Susceptibility Loci for Kawasaki Disease

    2009 · 297 citations
  12. Natural killer cells from human immunodeficiency virus (HIV)-infected individuals are an important source of CC-chemokines and suppress HIV-1 entry and replication in vitro.

    1998 · 291 citations
  13. Salivary gland tissue expression of interleukin‐23 and interleukin‐17 in Sjögren's syndrome: Findings in humans and mice

    2008 · 290 citations
  14. Single-Cell Characterization of Malignant Phenotypes and Developmental Trajectories of Adrenal Neuroblastoma

    2020 · 274 citations
  15. Intracerebral transplantation of bone marrow stromal cells in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease

    2001 · 271 citations
  16. Landscape of dietary factors associated with risk of gastric cancer: A systematic review and dose-response meta-analysis of prospective cohort studies

    2015 · 264 citations
  17. The bone microenvironment invigorates metastatic seeds for further dissemination

    2021 · 260 citations
  18. Use of MMTV-Wnt-1 transgenic mice for studying the genetic basis of breast cancer

    2000 · 255 citations
  19. EGFR-Induced and PKCε Monoubiquitylation-Dependent NF-κB Activation Upregulates PKM2 Expression and Promotes Tumorigenesis

    2012 · 245 citations
  20. Control of HIV-1 immune escape by CD8 T cells expressing enhanced T-cell receptor

    2008 · 243 citations
  21. Could gut microbiota serve as prognostic biomarker associated with colorectal cancer patients' survival? A pilot study on relevant mechanism

    2016 · 222 citations
  22. Oncogenic mTOR signalling recruits myeloid-derived suppressor cells to promote tumour initiation

    2016 · 216 citations
  23. A 36-week multicenter, randomized, double-blind, placebo-controlled, parallel-group, phase 3 clinical trial of sodium oligomannate for mild-to-moderate Alzheimer’s dementia

    2021 · 216 citations
  24. SAR1B senses leucine levels to regulate mTORC1 signalling

    2021 · 212 citations
  25. AR intragenic deletions linked to androgen receptor splice variant expression and activity in models of prostate cancer progression

    2012 · 202 citations

← Return to the university profile